The transcription factor zinc finger E-box binding homeobox 1 (ZEB1) has been identified as a key transcriptional regulator of EMT in prostate cancer, with its aberrant expression occurring partly in response to Insulin-like growth factor-I (IGF-I) IGF-I stimulation [87]. The gene discussed is ZEB1; the disease is prostate cancer.